Stem cell research and specialized treatments.
Active Pharmaceutical Ingredient repackaging and sales
Pharmaceutical reformulation, development and sales
Nesvik Pharmaceuticals, Inc., a Subsidiary of BioStem Technologies, Inc., Announces Engagement of The Gnomon Group fo...
September 17, 2018
Nesvik Pharmaceuticals, Inc., Receives Updated U.S. FDA Establishment Registration in Light of New Product Developmen...
August 28, 2018
BioStem Technologies, Inc. Completes 2016, 2017 Audit of Financial Statements
August 17, 2018
BioStem Technologies, Inc. Engages Maxim Group LLC For Strategic Advisory Services
August 15, 2018
BioStem Technologies, Inc. (OTC Pink: BSEM) Engages American Capital Ventures for Investor Relations Services
August 16, 2016
BioStem Technologies, Inc. (OTC Pink: BSEM) Begins Construction of New Laboratory Facility
July 13, 2016
BioStem Technologies Releases Third Quarter 2018 Shareholder Update
December 10, 2018
BioStem Technologies Selects PCG Advisory Group for Investor Relations and Strategic Communications
October 17, 2018
BioStem Life Sciences, Inc., Subsidiary of BioStem Technologies, Inc., Announces Entry into Market with Four Amniotic...
October 1, 2018
BioStem Technologies Inc. to Present at The MicroCap Conference on October 1st and 2nd in New York City at the Essex...
September 19, 2018